MVIS US Listed Pharmaceutical 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that derive at least 50% of their revenues from pharmaceuticals. The pure-play index contains only companies which are engaged primarily engaged in research (incl. research contractors) and development as well as production, marketing and sales of pharmaceuticals. Pharmacies are excluded. The MVIS US Listed Pharmaceutical 25 Index (MVPPH) has been licensed to underlie financial products with currently USD 190.62 million in assets under management.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights is available below.

Items 1-25 of total 25
ComponentCountryWeight
BRISTOL-MYERS SQUIBB COUS7.55%
ABBVIE INCUS5.61%
GLAXOSMITHKLINE PLC-SPON ADRGB5.10%
SANOFI-ADRFR5.07%
NOVO-NORDISK A/S-SPONS ADRDK5.03%
ASTRAZENECA PLC-SPONS ADRGB5.03%
ELI LILLY & COUS4.87%
JOHNSON & JOHNSONUS4.84%
MERCK & CO. INC.US4.83%
NOVARTIS AG-ADRCH4.71%
TAKEDA PHARM-ADRJP4.67%
PFIZER INCUS4.60%
BAUSCH HEALTH COS INCCA4.26%
ZOETIS INCUS4.15%
TEVA PHARMACEUTICAL-SP ADRIL4.04%
AMERISOURCEBERGEN CORPUS4.00%
MCKESSON CORPUS3.91%
MYLAN NVNL3.35%
AMARIN CORPORATION PLC -ADRGB3.31%
JAZZ PHARMACEUTICALS PLCIE3.05%
ELANCO ANIMAL HEALTH INCUS2.84%
PERRIGO CO PLCIE1.78%
CATALENT INCUS1.71%
GW PHARMACEUTICALS -ADRGB1.16%
PATTERSON COMPANIES INCUS0.56%
Items 1-25 of total 25
Up